US FDA approves Checkpoint’s skin cancer drug

(Reuters) – The U.S Food and Drug Administration said on Friday it has approved Checkpoint Therapeutics’ drug for treatment of two types of skin cancer.

(Reporting by Leroy Leo in Bengaluru; Editing by Krishna Chandra Eluri)